Maybe because HC posters cant read and understand anything in relation to trials. It is just what it is. Our cards are now played and out on the table and hand was not a royal flush just simply two pair. And now investor will punish that hand accordingly. What do want him to lie and sugar coat it. A year and half and only 5 evaluable patients is a shocker of data. Yes someone should be held accountable for that. However on the flip side, the drug seems to have real efficacy, a high MTD so high only one patient was needed for each dose cohort, and three out of five had SD from monotherapy. MONOTHERAPY....no confusion, no I wonder if that was our drug or the other drug. The drug worked in some part on people dying and it seems to have worked quickly.
Just remember if anything has failed or succeed it is the drug. Deal with it.
- Forums
- ASX - By Stock
- KZA
- JG Credibility
JG Credibility, page-7
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online